Role of gastric per-oral endoscopic myotomy (G-POEM) in post-lung transplant patients: a multicenter experience

Abstract

Background and study aims Gastroparesis post-lung transplant (LTx) can lead to increased risk of gastroesophageal reflux (GER) and accelerated graft dysfunction. We aimed to evaluate the efficacy and safety of gastric per-oral endoscopic myotomy (G-POEM), a promising tool in patients with refractory gastroparesis, for managing refractory gastroparesis and GER in post-LTx patients.

Patents and methods This was a multicenter retrospective study on post-LTx patients who underwent G-POEM for management of gastroparesis and GER that were refractory to standard medical therapy. The primary outcome was clinical success post-G-POEM. Secondary outcomes included the rate of post-G-POEM objective esophageal pH exam normalization, rate of gastric emptying scintigraphy (GES) normalization, technical success, and adverse events.

Results A total of 20 patients (mean age 54.7 ± 14.1 years, Female 50 %) underwent G-POEM at a median time of 13 months (interquartile range 6.5–13.5) post-LTx. All G-POEM procedures were technically successful. Clinical success was achieved in 17 (85 %) patients during a median follow-up time of 8.9 (IQR: 3–17) months post-G-POEM. Overall GCSI and two of its subscales (bloating and postprandial fullness/early satiety) improved significantly following G-POEM. Two patients (10 %) developed post-procedural AEs (delayed bleeding 1, pyloric stenosis 1, both moderate in severity). Post-G-POEM GES improvement was achieved in 12 of 16 patients (75 %). All 20 patients were on proton pump inhibitors pre-G-POEM, as opposed to five post-G-POEM. Post-G-POEM PH study normalization was noted in nine of 10 patients (90 %) who underwent both pre- and post-G-poem pH testing.

Conclusions G-POEM is a promising noninvasive therapeutic tool for management of refractory gastroparesis and GER post-LTx.

Publikationsverlauf

Eingereicht: 25. November 2021

Angenommen nach Revision: 17. Februar 2022

Artikel online veröffentlicht:
10. Juni 2022

• References

• 1 Sweet MP, Hoopes C, Golden J. et al. Prevalence of delayed gastric emptying and gastroesophageal reflux in patients with end-stage lung disease. Ann Thorac Surg 2006; 82: 1570 author reply 1570–1571
• 2 Suen HC, Hendrix H, Patterson GA. Physiologic consequences of pneumonectomy. Consequences on the esophageal function. Chest surgery clinics of North America 1999; 9: 475-483
• 3 Bobadilla JL, Jankowska-Gan E, Xu Q. et al. Reflux-induced collagen type v sensitization: potential mediator of bronchiolitis obliterans syndrome. Chest 2010; 138: 363-370
• 4 Verleden GM, Besse T, Maes B. Successful conversion from cyclosporine to tacrolimus for gastric motor dysfunction in a lung transplant recipient. Transplantation 2002; 73: 1974-1976
• 5 D'Ovidio F, Mura M, Ridsdale R. et al. The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules SP-A and SP-D. Am J Transpl 2006; 6: 1930-1938
• 6 Raviv Y, D'Ovidio F, Pierre A. et al. Prevalence of gastroparesis before and after lung transplantation and its association with lung allograft outcomes. Clin Transplant 2012; 26: 133-142
• 7 Ramkumar D, Schulze KS. Gastroduodenal motility. Curr Opin Gastroenterol 2003; 19: 540-545
• 8 Fass R, McCallum RW, Parkman HP. Treatment Challenges in the management of gastroparesis-related GERD. Gastroenterol Hepatol 2009; 5: 4-16
• 9 Kahrilas PJ. Clinical practice. Gastroesophageal reflux disease. N Engl J Med 2008; 359: 1700-1707
• 10 Pasricha PJ, Yates KP, Nguyen L. et al. Outcomes and factors associated with reduced symptoms in patients with gastroparesis. Gastroenterology 2015; 149: 1762-1774.e1764
• 11 Kashyap P, Farrugia G. Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut 2010; 59: 1716-1726
• 12 Ehrenpreis ED, Deepak P, Sifuentes H. et al. The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits. Am J Gastroenterol 2013; 108: 866-872
• 13 Camilleri M, Parkman HP, Shafi MA. et al. Clinical guideline: management of gastroparesis. Am J Gastroenterol 2013; 108: 18-37 ; quiz 38
• 14 Clarke JO, Sharaiha RZ, Kord Valeshabad A. et al. Through-the-scope transpyloric stent placement improves symptoms and gastric emptying in patients with gastroparesis. Endoscopy 2013; 45: E189-E190
• 15 Gourcerol G, Tissier F, Melchior C. et al. Impaired fasting pyloric compliance in gastroparesis and the therapeutic response to pyloric dilatation. Aliment Pharmacol Ther 2015; 41: 360-367
• 16 Arts J, Holvoet L, Caenepeel P. et al. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 2007; 26: 1251-1258
• 17 Wellington J, Scott B, Kundu S. et al. Effect of endoscopic pyloric therapies for patients with nausea and vomiting and functional obstructive gastroparesis. Autonom Neurosci 2017; 202: 56-61
• 18 Khashab MA, Stein E, Clarke JO. et al. Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video). Gastrointest Endosc 2013; 78: 764-768
• 19 Vosoughi K, Ichkhanian Y, Benias P. et al. Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial. Gut 2021;
• 20 Aghaie Meybodi M, Qumseya BJ, Shakoor D. et al. Efficacy and feasibility of G-POEM in management of patients with refractory gastroparesis: a systematic review and meta-analysis. Endosc Int Open 2019; 7: E322-E329
• 21 Spadaccini M, Maselli R, Chandrasekar VT. et al. Gastric peroral endoscopic pyloromyotomy for refractory gastroparesis: a systematic review of early outcomes with pooled analysis. Gastrointest Endosc 2020; 91: 746-752.e745
• 22 Podboy AJ, Clarke JO, Nguyen LA. et al. Gastric per-oral endoscopic myotomy for severe post-lung transplant gastroparesis: A single-center experience. J Heart Lung Transplant 2020; 39: 1153-1156
• 23 Khashab MA, Ngamruengphong S, Carr-Locke D. et al. Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video). Gastrointest Endosc 2017; 85: 123-128
• 24 Mekaroonkamol P, Dacha S, Wang L. et al. Gastric Peroral endoscopic pyloromyotomy reduces symptoms, increases quality of life, and reduces health care use for patients with gastroparesis. Clin Gastroenterol Hepatol 2019; 17: 82-89
• 25 Revicki DA, Rentz AM, Dubois D. et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 2003; 18: 141-150
• 26 Roman S, Gyawali C, Savarino E. et al. Ambulatory reflux monitoring for diagnosis of gastro‐esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group. Neurogastroenterol Motility 2017; 29: 1-15
• 27 Gyawali CP, Carlson DA, Chen JW. et al. ACG Clinical Guidelines: Clinical Use of Esophageal Physiologic Testing. Am J Gastroenterol 2020; 115: 1412-1428
• 28 Cotton PB, Eisen GM, Aabakken L. et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71: 446-454
• 29 Tougas G, Eaker EY, Abell TL. et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 2000; 95: 1456-1462
• 30 Khush KK, Cherikh WS, Chambers DC. et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Report-2018; Focus Theme: Multiorgan Transplantation. J Heart Lung Transplant 2018; 37: 1155-1168
• 31 Neujahr DC, Mohammed A, Ulukpo O. et al. Surgical correction of gastroesophageal reflux in lung transplant patients is associated with decreased effector CD8 cells in lung lavages: a case series. Chest 2010; 138: 937-943
• 32 Bodet-Milin C, Querellou S, Oudoux A. et al. Delayed gastric emptying scintigraphy in cystic fibrosis patients before and after lung transplantation. J Heart Lung Transplant 2006; 25: 1077-1083
• 33 Reid KR, McKenzie FN, Menkis AH. et al. Importance of chronic aspiration in recipients of heart-lung transplants. Lancet 1990; 336: 206-208
• 34 Berkowitz N, Schulman LL, McGregor C. et al. Gastroparesis after lung transplantation. Potential role in postoperative respiratory complications. Chest 1995; 108: 1602-1607
• 35 Sodhi SS, Guo JP, Maurer AH. et al. Gastroparesis after combined heart and lung transplantation. J Clin Gastroenterol 2002; 34: 34-39
• 36 Au J, Hawkins T, Venables C. et al. Upper gastrointestinal dysmotility in heart-lung transplant recipients. Ann Thorac Surg 1993; 55: 94-97
• 37 D'Ovidio F, Singer LG, Hadjiliadis D. et al. Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant. Ann Thorac Surg 2005; 80: 1254-1260
• 38 Hathorn KE, Chan WW, Lo WK. Role of gastroesophageal reflux disease in lung transplantation. World J Transplant 2017; 7: 103-116
• 39 Adegunsoye A, Strek ME, Garrity E. et al. Comprehensive Care of the lung transplant patient. Chest 2017; 152: 150-164
• 40 Ahmad S, Shlobin OA, Nathan SD. Pulmonary complications of lung transplantation. Chest 2011; 139: 402-411
• 41 Wang YR, Fisher RS, Parkman HP. Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995-2004. Am J Gastroenterol 2008; 103: 313-322
• 42 Wadhwa V, Mehta D, Jobanputra Y. et al. Healthcare utilization and costs associated with gastroparesis. World J Gastroenterol 2017; 23: 4428-4436
• 43 Lacy BE, Crowell MD, Mathis C. et al. Gastroparesis: quality of life and health care utilization. J Clin Gastroenterol 2018; 52: 20-24
• 44 Ichkhanian Y, Vosoughi K, Aghaie Meybodi M. et al. Correction to: Comprehensive analysis of adverse events associated with gastric peroral endoscopic myotomy: an international multicenter study. Surg Endosc 2021; 35: 1765
• 45 King BJ, Iyer H, Leidi AA. et al. Gastroesophageal reflux in bronchiolitis obliterans syndrome: a new perspective. J Heart Lung Transplant 2009; 28: 870-875
• 46 Lo WK, Burakoff R, Goldberg HJ. et al. Pre-lung transplant measures of reflux on impedance are superior to pH testing alone in predicting early allograft injury. World J Gastroenterol 2015; 21: 9111-9117
• 47 Tangaroonsanti A, Lee AS, Crowell MD. et al. Impaired esophageal motility and clearance post-lung transplant: risk for chronic allograft failure. Clin Translation Gastroenterol 2017; 8: e102
• 48 Blondeau K, Mertens V, Vanaudenaerde BA. et al. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Europ Respiratory J 2008; 31: 707-713